Experiment 67528
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | CASTANO,G: MAS,R: FERNANDEZ,JC: FERNANDEZ,L: ALVAREZ,E:. (2001). EFFECTS OF POLICOSANOL IN OLDER PATIENTS WITH TYPE II HYPERCHOLESTEROLEMIA AND HIGH CORONARY RISK.. 56A(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE PRESENT STUDY WAS UNDERTAKEN TO INVESTIGATE THE EFFECTS OF POLICOSANOL IN OLDER PATIENTS WITH TYPE II HYPERCHOLESTEROLEMIA AND MORE THAN ONE CONCOMITANT OTHEROSCLEROTIC RISK FACTOR. AFTER 6 WEEKS ON A LIPID-LOWERING DIET, 179 PATIENTS RANDOMLY RECEIVED A PLACEBO OR POLICOSANOL AT DOSE OF 5 FOLLOWED BY 10 MG PER DAY FOR SUCCESSIVE 12-WEEK PERIODS OF EACH DOSE. POLICOSANOL (5 AND 10 MG/D) SIGNIFICANTLY REDUCED LOW-DENSITY LIPOPROTEIN CHOLOESTEROL (LDL-C; 16.9% AND 24.4%, RESPECTIVELY) AND TOTAL CHOLESTEROL (TC; 12.8% AND 16.2%, RESPECTIVELY), WHILE SIGNIFICNATLY HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C) BY 14.6% AND 29.1%, RESPECTIVELY. |
| Dose amount | 10.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |